These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20938011)

  • 1. Rapid response of refractory ocular surface dysplasia to combination treatment with topical all-trans retinoic acid and interferon alfa-2b.
    Skippen B; Tsang HH; Assaad NN; Coroneo MT
    Arch Ophthalmol; 2010 Oct; 128(10):1368-9. PubMed ID: 20938011
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
    Dudney BW; Malecha MA
    Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of partial limbal stem cell deficiency with topical interferon α-2b and retinoic acid.
    Tan JC; Tat LT; Coroneo MT
    Br J Ophthalmol; 2016 Jul; 100(7):944-948. PubMed ID: 26508779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with 5-Fu.
    Schechter BA; Nagler RS
    Ophthalmology; 2003 Jun; 110(6):1262-3; author reply 1263. PubMed ID: 12799258
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment with 5-Fu.
    Schechter BA; Nagler RS
    Ophthalmology; 2003 Apr; 110(4):625-6; author reply 626. PubMed ID: 12689863
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of CIN with retinoic acid and topical interferon alfa-2b.
    Huerva V
    Ophthalmology; 2013 Aug; 120(8):e55. PubMed ID: 23916085
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of topical retinoic acid for limbal stem cell failure: a retrospective clinical case series.
    Chew SK; Watson S
    Clin Exp Ophthalmol; 2016 Apr; 44(3):217-8. PubMed ID: 26433208
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitomycin C therapy for corneal intraepithelial neoplasia masquerading as limbal stem cell deficiency with recurrent epithelial defect.
    Gokhale NS
    Int Ophthalmol; 2011 Apr; 31(2):161-3. PubMed ID: 21327677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Wilson MW; Hungerford JL; George SM; Madreperla SA
    Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent intraepithelial neoplasia treatment.
    Schechter BA; Nagler RS; Schrier A
    Ophthalmology; 2005 Jul; 112(7):1319; author reply 1319. PubMed ID: 15993243
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Sinha B; Kumar R
    Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
    Haas K; Ben-Dor D; Levartovsky S
    Arch Ophthalmol; 1999 Apr; 117(4):544-5. PubMed ID: 10206591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.